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ABSTRACT 
Soft tissue calcification occurs in pathologies such as atherosclerosis and diabetes and 
genetic disorders like pseudoxanthoma elasticum (PXE). PXE is caused by mutations in 
ABCC6 and its symptoms include calcification in the skin, eyes, and cardiovascular 
tissues. ABCC6 is expressed primarily in the liver and kidneys and mediates the efflux 
of ATP. The released ATP is rapidly degraded by the ectocnucleotidases ENPP1 and 
NT5E into adenosine and pyrophosphate (PPi), with PPi being a potent inhibitor of 
calcification. Thus, ABCC6 is an upstream regulator of a pathway that modulates PPi 
production and adenosinergic signaling affecting ectopic calcification. The Abcc6-/- mice 
display calcification symptoms similar to human PXE patients in addition to an acute 
and inducible dystrophic muscle calcification phenotype. We hypothesize 1) the lack of 
Abcc6 lowers ATP efflux and influences the expression of Enpp1 and Nt5e, thereby 
impacting plasma PPi levels and calcification susceptibility and 2) ABCC6 deficiency 
causes dystrophic calcification in cardiac tissues and skeletal muscle. The aims of this 
study were to 1) characterize the muscle calcification phenotype, 2) explore gene 
expression of the “Abcc6 pathway” and its molecular players, and 3) supplement PPi to 
counteract skeletal muscle calcification. Our inability to reproduce previous 
gastrocnemius calcification data for Aim 1 despite multiple trials and attempting protocol 
optimization led to the discovery of elevated levels of PPi in the rodent chow. 
Surprisingly, reversion to a low PPi diet did not restore the calcification phenotype and 
instead reduced calcium deposits in muscle tissues. The testing of an acceleration diet 
designed to enhance calcification was infructuous as it produced mineralization even in 
wild type mice. Our results demonstrated the impact that animal chow can have on 
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phenotypic outcome. Moreover, our data may provide an explanation for the phenotype 
variability in PXE patients and further suggested that dietary intervention to slow the 
progression of the calcification phenotype of PXE in patients may be possible. Gene 
expression studies showed positive correlation between the Abcc6 status and Enpp1 
and Nt5e mRNA levels in heart tissues. However, since we showed that PPi 
supplementation influences the expression of Enpp1, the presence of high levels of PPi 
in mouse chow probably negatively influenced our data. The Aim 3 experiments could 
not be completed as planned since we discovered elevated levels of PPi in the animal 
diet. However, results of specific Aim 1 provided some indications that indeed 
supplementation with PPi can effectively suppress dystrophic calcification in muscle 
tissues. Overall, the discovery of the elevated levels of PPi in the diet prevented us from 
achieving some of the goals of our specific aims and produced unanticipated but 
valuable data. Collectively, these studies have improved our understanding of the role 
of Abcc6 and PPi in the inhibition of soft-tissue calcification.  
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CHAPTER 1: INTRODUCTION 
Calcification 
Calcium metabolism is a complex and closely regulated biological process that is 
usually associated with the formation of teeth and bones [1]. Calcium and phosphate 
(PO43-) are the principal components of organized hydroxyapatite crystals 
(Ca10(PO4)6OH2). At physiological concentration, the concentrations of Ca2+ and PO43- 
are near saturation and crystallization can occur readily. Because of this, the body 
employs several processes to ensure these ions are maintained at specific physiological 
concentrations and suggests plasma contains inhibitory factors that help regulate 
mineralization [2] [3].  
Calcium plays a key role in cellular processes including hormone secretion, 
muscle contraction, and nerve conduction. It also acts as a secondary messenger that 
transmits extracellular information and signals to the interior of the cell. Due to its many 
functions, the physiologically active free ionic form of Ca2+ in the plasma is carefully 
maintained in a narrow range (between 1.0 and 1.3 mM) with the help of ion channels, 
certain organelles, and specialized transporters [4]. Most of the body’s calcium is 
located within the bones and teeth while the rest exists in plasma as a free ionic 
species, associated with serum proteins, or bound to lower-molecular weight anions.   
Phosphate is also essential for various physiological processes and, like calcium, its 
physiological levels are tightly regulated. Phosphate is important for bone formation and 
for its role in energy formation with phosphate being an essential component of the 
adenosine triphosphate (ATP) molecule. The body uses phosphate derived compounds 
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in many biological activities such as cell signaling, enzyme function, and waste 
excretion [5] [4]. 
ABC Transporters 
ATP-binding cassette (ABC) transporters are an important class of membrane-
bound protein pumps. The human proteome consists of 48 ABC proteins, which are 
grouped into seven subfamilies from A to G based on sequence similarity. These 
proteins may function as unidirectional (efflux) pumps that hydrolyze ATP to export 
many molecules from the cytoplasm into the extracellular space, and their presence in 
the intestinal tract and blood brain barrier is instrumental for removing toxic molecules 
[6]. These proteins can also regulate nearby ion channels and function as an ion 
channel [3]. 
ABC proteins have the same general structural features. The proteins are made 
up of two transmembrane units, and each unit is comprised of six membrane-spanning 
a-helices that are connected to two intracellular ATP-binding subunits just beneath the 
plasma membrane.  The binding of ATP induces a conformational change that exposes 
a substrate-specific binding site. Once ATP is hydrolyzed, ADP dissociates and the 
transporter returns to its original conformation [6]. 
ABCC6 
The ABCC subfamily has 12 members with the majority of them acting as active 
transporters [7]. This subfamily of proteins notably includes ABCC7 (also known as 
CFTR) which is associated with cystic fibrosis. ABCC6 is also known as multidrug 
resistance-associated protein 6 (MRP6) and ABCC6 is located at 16p13.11 on 
chromosome 7. The functional gene spans 75 kD and consists of 31 exons. The ABCC6 
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/MRP6 protein is made up of 1503 amino acids and functions as an organic anion 
transporter [8] [9] . ABCC6 is primarily expressed in the liver with lower levels of 
expression in the kidney, though many other cell types also express detectable levels of 
the protein [10] [11].  
As for all other ABC proteins, the ABCC subfamily of proteins consists of the core 
structure of two nucleotide-binding domains and two transmembrane domains (TMDs) 
with six transmembrane helices. ABCC1, 2, 3, 6, 8, 9, and 10 have two unique structural 
features located N-terminally: the TMD0 domain comprised of five membrane spanning 
helices that connects with the other transmembrane helices via an intracellular loop (L0) 
[7]. Homology models (igure 1) depict ABCC6 with the ABC domains located in close 
proximity to each other, forming a head-to-tail dimer. 
 
 
 
 
 
 
 
 
 
Figure 1: The three-dimensional homology model of the ABCC6 protein.  
A) Schematic representation of domain swapping of ABC proteins B) Three-dimensional model of the 
outward facing conformation C) Three-dimensional nucleotide-free confirmation. 
 
A B C
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Pathologic Calcification 
Pathological (ectopic) calcification is characterized by the deposition of 
hydroxyapatite crystals in the soft tissues. Dystrophic calcification is a type of pathologic 
calcification that occurs specifically in response to injury. For example, the tissue 
damage that occurs during surgical procedures initiates an inflammatory response that 
occasionally results in calcification of the soft tissues. Most soft tissue calcification may 
be visualized with X-rays [12].  The presence of dystrophic calcification increases the 
risk for developing heterotopic ossification, the formation of bone outside of its normal 
place [12].  
Pathologic calcification is also common to several naturally occurring pathologies 
such as diabetes, renal failure, hypercholesterolemia, and certain genetic disorders [13].  
The small and middle-sized arteries of the cardiovascular system are especially 
susceptible to calcification and are associated with symptoms including, but not limited 
to, diminished peripheral pulses, hypertension, and atherosclerosis.  
The delicate balance of calcium metabolism is influenced by multiple internal and 
external factors such as aging, tissue injury, diet, chronic renal insufficiency, and 
diabetes [14]. Genetic risk factors include mutations in genes that cause the heritable 
diseases pseudoxanthoma elasticum (PXE) and generalized arterial calcification of 
infancy (GACI), where pathologic calcification is the most detrimental side effect, as well 
as calcification of the joints and arteries (CALJA), formally known as arterial calcification 
due to deficiency of CD73 (ACDC). In depth studies of these diseases have provided a 
better understanding of how the regulation of specific genes may contribute to biological 
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calcification. The wide range of complications associated with pathologic calcification 
make it an important area of research. 
In contrast to dystrophic calcification, metastatic calcification results from 
elevated extracellular levels of calcium (hypercalcemia) that exceed the normal 
homeostatic levels [12]. Mineralization may occur in cells and extracellular matrix 
components like collagen, basement membranes, elastic fibers, and arterial walls. 
Metastatic calcification is linked to pathologies such as renal failure and 
hyperparathyroidism and on X-ray appears as fine, diffuse speckles throughout soft 
tissue [12].   
Pseudoxanthoma elasticum (PXE) 
Mutations in ABCC6 have been linked to PXE. The prevalence of PXE is known 
and is estimated at 1 in 25,000 to 1 in 50,000 [15]. In 2000, positional cloning 
experiments linked loss-of-function mutations in both alleles of ABCC6 directly to the 
pathogenesis of pseudoxanthoma elasticum [16]. Up to now, more than 400 mutations 
have been identified with disease-causing changes resulting from single nucleotide 
substitutions and small and large deletions [17]. The most common loss-of-function 
mutations identified in PXE are p.R1141X (20-30) and c.EX23_29del [18].   
PXE is an autosomal recessive disease of the connective tissue causing 
progressive peripheral ectopic calcification of the skin, eyes, and arteries. Presently, 
there are no effective therapies for PXE [11]. The hallmark symptom of PXE is the 
formation of yellowish papules in the skin that eventually coalesce to form distinct 
plaques (Figure 2A). The flexor surfaces of the body, such as the axilla (Figure 2B) and 
groin, develop redundant folds due to increased skin laxity and results in a prematurely 
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aged appearance (Figure 2) [19] [20]. The inelasticity of the skin can be visualized by 
histopathologic analysis of the skin lesions of PXE patients (Figure 2C), which depict 
mineralization of the dermal collagen fibers [19]. 
  
 
Figure 2: PXE symptoms in the skin.  
The flexor surfaces such as the neck and axilla exhibit distinct plaques (A,B). Histopathological analysis 
of the skin confirms calcification (scale 500 µM) (C). 
The eyes and cardiovascular tissues are also affected by calcification and are 
responsible for the morbidity of PXE [17]. Examination of the fundus shows angioid 
streaks, which represent breaks in the Bruch’s membrane (Figure 3B). These breaks 
may lead to choroidal neovascularization, hemorrhages (Figure 3C), and eventually loss 
of central vision. Cardiovascular tissues are affected with early onset of atherosclerosis 
[7]. The hardening of the leg arteries (Figure 3D) causes intermittent claudication while 
calcification of the coronary artery increases risk for myocardial infarction [19]. ABCC6 
has also been classified as a potential genetic risk factor in coronary artery disease 
(CAD) [14]. Other complications include hypertension, arterial insufficiencies in the 
extremities, and gastrointestinal hemorrhages [20].     
The clinical manifestations of PXE are highly varied and the severity of 
symptoms differs extensively among families with no clear genotype-phenotype 
correlation. This phenotypic heterogeneity of PXE adds a layer of complication when 
Skin Calcification
A B C
Pomozi et al, 2017 
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studying the disease. Diagnosis can be difficult since symptoms typically do not appear 
until puberty. Additionally, establishing the correct diagnosis is difficult since the clinical 
conditions are identical to pathologies of other disorders [19].   
 
 
 
 
 
Figure 3: Cardiovascular and ocular PXE 
symptoms. 
Calcification may occur in major arteries such 
as the major iliac arteries (white arrows) in 
the leg (A). Ocular symptoms result from 
calcification of the Bruch’s membrane (white 
arrows) (B) that in turn causes retinal 
hemorrhaging (C) and eventually leads to 
macula scarring and a loss of central vision 
(D). 
 
Generalized Arterial Calcification of Infancy (GACI) 
The other genetic disease resulting, in part, from ABCC6 mutations is a rare 
autosomal recessive disorder called generalized arterial calcification of infancy (GACI). 
It is characterized by severe pathologic calcification of the arterial media and intimal 
layers and loss of integrity of the elastic fibers, ultimately culminating in severe arterial 
stenosis ( 
A B
C
D
Cardiovascular & Ocular PXE symptoms
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Figure 4) [1]. Other symptoms include congestive heart failure, hypertension, and 
myocardial ischemia. Most patients die within the first six months of life, while some 
others treated with bisphosphonates had better outcomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
GACI
Aortic calcification (ultrasound) Aortic calcification (H&E staining)
Periarticular calcification (X-ray)
Nitschke et al, 2012 
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Figure 4: Severe calcification of cardiovascular and periarticular tissues in GACI.  
X-ray visualization of periarticular calcification (white arrows) (A,B). Aortic calcification seen on ultrasound 
(white arrows) (C) and with H&E staining (black arrows) (D). 
A loss-of-function mutation in ENPP1 accounts for 75% of the GACI cases. ENPP1 
encodes for an ectonucleotide pyrophosphatase that preferentially hydrolyzes ATP to 
form PPi, and therefore plays an important role in bone mineralization [21]. Interestingly, 
a significant portion of patients with GACI also carried ABCC6 mutations while some 
PXE patients only carry ENPP1 mutations [22]. This study showed that patients with 
GACI had PXE-like symptoms such as angioid streaks and identical skin lesions. These 
findings were the first indication that ENPP1 and ABCC6 are linked through a molecular 
pathway contributing to calcification [1]. 
Calcification of Joints and Arteries (CALJA) 
The disease CALJA is characterized by adult onset calcification of the lower 
extremities in the iliac, femoral, and tibial arteries, as well as in the hand and foot 
capsule joints. It is an autosomal recessive condition caused by mutations in NT5E, 
which encodes the adenosine-generating ecto5’-nucleotidase that catalyzes the 
conversion of adenosine monophosphate (AMP) into adenosine and inorganic 
phosphate (Pi) [23]. Identifying mutations in NT5E was the first indication that altered 
purinergic signaling could modulate calcification from insufficient adenosine production 
and activation of tissue non-specific alkaline phosphatase (TNAP/ALPL) [24]. Indeed, 
CALJA is caused by enhanced PPi degradation due to the activation of TNAP [25, 26], 
which degrades PPi into Pi, an activator of calcification. 
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Mouse Models 
Use of Abcc6-/- mice has been instrumental in the study of PXE. Past studies 
demonstrate the phenotype of Abcc6-/- mice duplicates rather faithfully the human PXE 
pathology, though there are divergent areas of mineralization between mice and 
humans. Starting shortly after weaning, both male and female mice develop progressive 
calcification of renal vessel walls without affecting renal function. In older animals, 
elastic fibers in the vessel walls of other large and medium-sized arteries develop 
calcium deposits, mirroring the cardiovascular pathologies of PXE patients [20].  
Unlike human PXE patients, mice did not show significant calcification of the dermis or 
flexor areas. Calcification of the ocular Bruch’s membrane is comparable to their human 
counterparts, though it’s unclear if the mice develop angioid streaks, retinal 
hemorrhages, and/or lose vision. Remarkably, mineralization in mice is first detected in 
vibrissae, a connective tissue capsule that surrounds the hair bulb of each vibrissa in 
muzzle skin, a tissue not present in humans [27]. The vibrissae calcification serves as a 
useful marker of disease progression in Abcc6-/- mice and is first detectable at 5 to 6 
weeks of age, increasing progressively with time [19]. Overall, these similarities in the 
calcification phenotype between mice and humans make Abcc6-/- mice an excellent 
model for investigating PXE. 
Calcification Phenotypes 
Calcification associated with ABCC6 deficiency can be subdivided into two 
distinct phenotypes: a chronic and passive manifestation and an acute inducible 
phenotype. The main PXE phenotype is characterized by long-term, chronic calcification 
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affecting primarily elastic fibers within the extracellular matrix of skin, arteries, and 
retina. This phenotype is progressive and irreversible [18] [28].  
The other phenotype is referred to as dystrophic cardiac calcification or DCC. 
Several commercially available strains of mice (C3H/HeJ, DBA/2J, and 129S1/SvJ) 
were described years ago [29] as developing severe dystrophic calcification after 
cardiovascular injuries, ischemia, or high fat diets [30]. Examination of F2 intercrosses of 
C57BL/6J and susceptible animals C3H/HeJ mice (also called C3H) identified a major 
susceptibility locus, Dyscalc1, on chromosome 7 [31] [32]. Within this locus, a single 
specific Abcc6 mutation resulted in a constitutive decrease in Abcc6 protein levels in 
liver and is directly responsible for the DCC phenotype [10, 29]. Additional minor 
Dyscalc loci were also identified (Dyscalc2 to 4) and mapped to chromosomes 4, 12, 
and 14. These modifier loci affect the penetrance and expression of the DCC phenotype 
[30]. DCC occurs independently of calcium and phosphate homeostasis. 
 23 
 Unlike passive PXE-like calcification, DCC is acute, develops over a very short 
period of time, and affects all muscular tissues including skeletal muscle ( 
). Furthermore, DCC occurs intracellularly, seemingly initiated within mitochondria. 
Therefore, the chronic and acute molecular pathways leading to calcification probably 
share a mechanism of initiation (Abcc6 deficiency) but their progressions are distinct 
[14]. The main characteristics of DCC, inducibility and rapid development (within days), 
have been effectively used by Dr. Le Saux’s laboratory as a convenient research tool to 
expand our understanding of ABCC6 and to develop strategies to treat PXE patients ( 
) [14, 33, 34]. In this research project, we focused on the molecular characteristics of 
DCC. 
 
Figure 5: Cryoinjury induces the DCC phenotype and causes increased cardiac calcium 
deposition.  
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A robust calcium deposition in Abcc6-/- mice induced by freeze-thaw injury in 2-4 days (A,E). The Abcc6+/- 
mice (B,E) and Abcc6-/- sham control (C,E) did not show abnormal calcification. The green bar (E) 
represents the transient expression of Human ABCC6 (HuABCC6) in liver, which significantly reduced 
cardiac calcification. 
 
The Proposed “ABCC6 pathway” 
An “ABCC6 pathway” has been proposed with several key molecular players. ABCC6 
seems to initiate molecular processes leading to pyrophosphate generation, which 
prevents abnormal calcification [34]. In this model ( 
Figure 6), ABCC6, located on the basolateral side of hepatocytes (and other cell types) 
mediates the cellular efflux of ATP. The AMP indirectly inhibits calcification by inhibiting 
tissue-nonspecific alkaline phosphatase (TNAP) synthesis. The absence of TNAP 
prevents the breakdown of PPi into Pi, which would otherwise activate soft-tissue 
calcification [26]. 
 
 
 
Figure 6: The proposed ABCC6 pathway inhibits ectopic calcification.  
ABCC6 facilitates the cellular efflux of ATP from liver and other tissues/cells, which is 
quickly converted to pyrophosphate (PPi), a potent inhibitor of mineralization. 
Decreased plasma PPi levels cause calcification in PXE and GACI. NT5E activity leads 
Figure 1: The ABCC6 pathway inhibits calcification. ABCC6 facilitates the cellular efflux of 
ATP from liver and other tissues/cells, which is quickly converted to pyrophosphate (PPi), a 
potent inhibitor of mineralization. Decreased plasma PPi levels cause calcification in PXE and 
GACI. NT5E activity leads to adenosine production, which inhibits TNAP expression. TNAP 
otherwise degrades PPi into inorganic phosphate (Pi), an activator of calcification.
AMP
PPi
ATP
ABCC6 eNPP1 NT5E TNAP                 PiAdenosine
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to adenosine production, which inhibits TNAP expression. TNAP otherwise degrades 
PPi into inorganic phosphate (Pi), an activator of calcification.  
Inorganic Pyrophosphate (PPi) 
In humans, inorganic pyrophosphate (PPi) is found mainly in body fluids, but is 
also present in blood cells, calcified tissues, bone, and teeth. Inorganic pyrophosphate 
(PPi) is a by-product of many in vivo biosynthetic reactions. There are various PPi 
forming reactions in multiple regions of metabolism that involve proteins, carbohydrates, 
lipids, and nucleic acids [2]. These PPi-producing reactions include but are not limited 
to: synthesis of aminoacyl-tRNA, activation of carboxylic acids, protein degradation and 
modification, and nucleotide synthesis [2].  
PPi is essential to calcium metabolism because it is a known inhibitor of 
calcification and works by preventing the crystallization of Ca2+ and PO43  [35]. Early in 
vivo and in vitro studies showed that hydroxyapatite crystals coated with PPi grew and 
dissolved much slower compared to controls [2]. Additionally, PPi inhibited the 
conversion of amorphous calcium into crystalized hydroxyapatite [2]. Conversely, 
alkaline phosphatases promote calcification by hydrolyzing PPi into inorganic phosphate 
(Pi) that can then form hydroxyapatite crystals with Ca2+.  
Previous studies in our laboratory characterized the structural and functional 
consequences of PXE-causing mutations in ABCC6. Three possible consequences 
were identified: 1) transport deficiency due to inability to use ATP, 2) altered protein 
folding and stability, causing the protein to be retained intracellularly, and 3) reduced 
trafficking efficiency but with normal in vitro transport activity [37]. Consequently, the 
missense ABCC6 mutations studied all resulted in a loss of the physiological function, 
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thus providing a possible explanation for the lack of genotype-phenotype correlation in 
PXE. In vitro assays further confirmed that most of the mutants had abnormal cellular 
localization, where the ABCC6 protein failed to reach the plasma membrane in cultured 
cells and mouse liver. This confirms that PXE is not caused by a lack of ABCC6 in the 
tissues, but instead by the absence of the PPi it effluxes into circulation. 
The levels of PPi in circulation became a topic of interest once ABCC6 was 
shown to efflux ATP, which is subsequently degraded into PPi at the cell surface. 
Generally, ATP is considered to stay inside living cells, but has been shown to exist in 
extracellular fluids. It is thought that ATP may enter the plasma after being excreted 
from blood platelets undergoing degranulation, via synaptic vesicles, and from smooth 
muscle cells through mechanisms not yet understood [2]. 
The link between ABCC6 and plasma PPi was supported by experimental 
evidence as Abcc6-/- mice have plasma PPi levels ~40% that of WT mice. Moreover, 
PXE patients present similarly lowered plasma PPi concentrations (~2.5 fold lower) as 
compared to healthy individuals [11] [36]. This suggests that ABCC6 accounts for 
approximately 60% of the PPi plasma levels in mice and humans [33]. Taken altogether, 
the proposed pathway ( 
Figure 6) and experimental evidence links decreased levels of plasma PPi to 
pathological calcification. 
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CHAPTER 2: MATERIALS AND METHODS 
Animals 
The Abcc6tm1JfK mice (referred to in this study as Abcc6-/- mice) were developed 
by targeted ablation of the mouse Abcc6 gene. These mice were made on the 
129S1/SvImJ background and backcrossed on C57BL/6J background >10 times [27]. 
Inbred C57BL/6 and C3H/He strains were purchased from Charles River (Sulzbach-
Rosenberg, Germany) [38]. The congenic strains were bred at the John A. Burns 
School of Medicine (JABSOM) Vivarium. The outset (C57BL/6 × C3H/He) F1 male mice 
were backcrossed to female C57BL/6 mice. Selected progeny were further backcrossed 
to female C57BL/6 mice for nine more generations with the aim to preserve (C57BL/6 × 
C3H/He) heterozygosity on proximal chromosome 7. DNA was isolated from each F2 
animal and genotyped using microsatellite markers D7Mit56, D7Mit247, D7Mit229, 
D7Mit82, D7Mit31, D7Mit40, and D7Mit33 [32].  Brothers and sisters were mated to 
produce a chromosome segment with homozygous alleles of the susceptible donor 
strain C3H/He. Throughout the entire experiment, all animals had free access to water 
and the standard rodent diet Altromin 1324 chow. The accelerated diet (Acc) contains 
specific mineral modifications to induce calcification in the Abcc6-/- mouse model. In 
comparison to the standard rodent diet, the Acc diet has a 2-fold increase in absorbable 
phosphorus (from 0.43% to 0.85%), a 22-fold increase in vitamin D3 (from 4.4 IU/g to 
100 IU/g), and a decrease in calcium (from 1.0% to 0.4%) and magnesium (from 0.22% 
to 0.04%). Mice were maintained with a 12-hour light and dark cycle. The animal studies 
were approved by the Institutional Animal Care and Use Committee (IACUC) of 
JABSOM. 
 28 
 
Survival Surgeries 
Myocardial Cryoinjury 
The WT and Abcc6-/- mouse strains ranging from 2-12 months in age underwent 
myocardial freeze-thaw injury. Mice were anesthetized with 5% isoflurane through nasal 
inhalation for 3-5 minutes then maintained at 3% throughout the procedure. A vertical 
incision was made to the midline of the abdomen through the skin, abdominal muscles, 
and peritoneal wall. The left lobe of the liver was lifted gently to visualize the beating 
heart through the translucent diaphragm. The probe (5 mm in diameter) was first cooled 
in liquid nitrogen for approximately 2 minutes and then gentle pressure was applied 
through the diaphragm to the heart for 10 seconds. The incision was closed in layers, 
starting with the abdominal muscle layer closure using 6.0 silk suture material and 
discontinuous sutures. Next the skin layer was closed using the same suture material 
and continuous sutures. The mice were sacrificed using carbon dioxide at either 3 or 7 
days post-surgery [14]. 
Skeletal Muscle Cryoinjury 
Mice ranging in age from 2-12 months from both WT and Abcc6-/- mouse strains 
underwent gastrocnemius (calf muscle) freeze-thaw injury. Mice were anesthetized with 
5% isoflurane through nasal inhalation for 3-5 minutes then maintained at 3% 
throughout the procedure. While mice were positioned on their abdomens, an 8-mm 
incision was made through the skin and forceps were used to expose the underlying 
muscle. A single suture was made directly into the muscle using 6.0 suturing material. 
The probe (5 mm in diameter) was first cooled in liquid nitrogen for approximately 2 
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minutes, then gently pressed directly onto the suture for 30 seconds. The skin layer was 
closed using 6.0 suturing material and continuous sutures. The mice were sacrificed 
using carbon dioxide at 3 or 7 days post-surgery. 
 
PPi Supplementation 
PPi was purchased from Sigma-Aldrich (St. Louis, MO) as tetrasodium 
decahydrate salt. Based on a previous study [28], 100 mg/kg per day of PPi in 0.9% 
saline solution was administered to mice via intraperitoneal (ip) injection. Injections were 
initiated 24 hours before induction of DCC via cryoinjury and daily thereafter until 
euthanasia. Control animals received injections of saline. For the experimental groups 
of mice testing the effect of PPi on chronic calcification, the animals were weighed every 
week and the volume injected was adjusted accordingly. For control experiments, 
groups of mice were treated in parallel with saline injections. Cardiac and 
gastrocnemius tissues were harvested at day 7 after injury, as described above [34]. 
 
Histochemistry 
Alizarin Red 
For histochemical staining, the mice were euthanized by CO2 asphyxiation either 
3 or 7 days post cryoinjury depending on the procedure chosen. The diaphragm, 
peritoneal muscle, sutured abdominal skin, control and injured heart, and control and 
injured gastrocnemius muscle were fixed in 10% neutral buffered formalin (NBF) 
overnight, then stored in 70% EtOH at 4°C prior to paraffin embedding. Paraffin sections 
(5 µM thick) were stained with Alizarin Red S solution (Sigma, St., Louis MO) for 5 
minutes and mounted using Permount (Fisher Scientific, Waltman, MS).  Images were 
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collected using an Axioscope 2 fluorescent microscope (Zeiss, Thornwood, NY) and 
sections from each treatment group were visualized for calcium deposition [14]. 
 
H&E  
The tissue samples for H&E staining were harvested in parallel with the Alizarin 
Red staining samples and stored overnight in 10% neutral buffered formalin (NBF) as 
described above. The biopsy specimens were embedded in paraffin and the sections (5 
µM thick) were stained with hematoxylin and eosin and mounted using Permount 
(Fisher Scientific, Waltman, MS). 
 
Quantification Assays 
Colorimetric Calcium Measurement 
The amount of calcium mineralization in the tissues was quantified using a 
colorimetric assay [39]. This assay directly measures the amount of calcium within 
excised tissue, and is normalized to the weight of the dry tissue. Excess tissue calcium 
(above background levels) reflects mineralization. For hearts, the atria were removed 
and only the ventricular area was used. For gastrocnemius muscle samples, the injured 
part of the muscle was distinguished from the uninjured parts with the single suture 
positioned at the time of injury and selectively excised. Heart and muscle tissue were 
placed in 0.15N HCl and incubated at room temperature for 48 hours. Samples were 
centrifuged at 13,200 rpm, and the total calcium content of the HCl supernatant was 
measured using the Calcium Liquicolor Kit (Stanbio, Boerne, TX) by measuring 
absorbance at 550 nm. The amount of calcium was normalized to the total dry tissue 
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weight before mincing. The calcium values were quantified against a known standard 
and expressed in µg/dL per milligram of tissue [18]. 
 
Pyrophosphate Measurement of Food- viola uses different protocol 
PPi was extracted from 2.5 g of grounded chow in 15 ml of sterile Milli-Q water. 
The sample was agitated at 4˚C overnight then centrifuged. PPi was measured from the 
supernatant. The kit uses p-nitrophenyl phosphate as substrate, which is converted into 
colored p -nitrophenol measured by optic density at 405 nm. Units of alkaline 
phosphatase activity correspond to mmol of p-nitrophenol/mL per minute. ATP was 
measured in perfusion samples, as previously described, and in plasma using the 
Promega, G8230 BacTiter-Glo Microbial Cell Viability Assay from Promega (Madison, 
WI). 
 
Molecular Biology Methods 
RNA Isolation 
Total RNA was extracted from tissue samples ranging in weight from 25-30 mg. 
Tissues were harvested and placed in RNAlater overnight, then weighed and placed 
into 50 µL of 1X PBS. Tissues were minced and digested in 500 µL of Trizol for 5 
minutes, then 100 µL of chloroform were added. Samples were centrifuged for 15 
minutes at 12,000 g at 4°C. The colorless supernatant was separated and total RNA 
was extracted using the RNeasy kit (Qiagen Inc., Valencia, VA).  
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cDNA synthesis 
RNA was converted into first-strand cDNA using the SuperScript III First-Strand 
synthesis kit with random hexamers (ThermoFisher, Waltham, MA).  The extracted RNA 
was combined with the appropriate amount of RNase-free water to obtain a 
concentration of 200 ng/µL. Next, 1 µL of RNAse free water, 1 µL of primer, and 1 µL of 
annealing buffer was added to each reaction. The samples were incubated at 65°C for 5 
minutes then 4°C for 1 minute. 10 µL of 2X First-Strand Reaction Mix and 2 µL of 
SuperScript III Enzyme Mix were added and the samples were incubated for 5 minutes 
at 25°C, 50 minutes at 50°C, 5 minutes at 85°C, and 4°C forever. Samples were stored 
at -20°C until needed for RT-qPCR. 
 
Reverse Transcriptase Quantitative PCR (RT-qPCR) 
The RT-qPCR was carried out using the Applied Biosystems StepOnePlus RT-
PCR system and the Design Wizard StepOne software (Applied Biosciences Inc., 
Foster City, CA).  The levels of expression of mouse Enpp1 (Life Technologies, 
Mm01193761_m1) Nt5e (Life Technologies, Mm00501910_m1), Abcc6 (Life 
Technologies, Mm01202683), and reference gene Gapdh (Life Technologies, 
Mm99999915) were detected using commercially available T 
aqMan probes (Applied Biosciences Inc., Foster City, CA). The StepOne 
software pre-determined the volume of each reagent needed to achieve appropriate 
concentrations and quantities for each reaction. First, the samples were prepared by 
combining RNAse free water and the cDNA stock solution of each sample in 
microcentrifuge tubes to achieve a concentration of 150 ng/µL. Next, the reaction mix 
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was made using TaqMan Mastermix, RNAse free water, and the appropriate TaqMan 
probe Assay Mix. The reactions were arranged in accordance with the plate layout 
made with StepOne Design Software. Each sample contained 59.4 µL of reaction mix 
and 6.6 µL of sample for a final volume of 65 µL. The negative control reactions 
contained 39.6 µL of reaction mix and 4.4 µL of RNAse free water to a final volume of 
44 µL. Lastly, 20 µL of each sample was pipetted into the appropriate wells to make 
triplicates.  
The samples were placed Applied Biosystems StepOnePlus RT-PCR system 
(Applied Biosciences Inc., Foster City, CA) and run on the following program: holding 
stage for 2 minutes at 50°C and 10 minutes at 95°C, then the cycling stage for 40 cycles 
at 95°C for 15 seconds then 1 minute at 60°C. Results were collected by the StepOne 
software. 
 
Statistical Analysis 
Data was analyzed using the statistical software PRISM 7 (GraphPad, San 
Diego, CA). Analyses were performed using two-tailed unpaired Student’s t-tests to 
determine the statistical difference between the injured and control Abcc6-/- and WT 
groups. Results were expressed as means + SEM and considered significant for p < 
0.05.  
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CHAPTER 3: RESULTS 
Specific Aim 1:  
Characterize the muscle calcification phenotype by quantifying the amount of calcium 
and visualizing the phenotype histologically. 
 
Hypothesis:  
Abcc6 deficiency causes dystrophic calcification in all muscle tissues, including skeletal 
muscles. 
 
Preliminary Data 
Skeletal Muscle Calcification Phenotype  
 Previous work in our laboratory studied the role of Abcc6 in the DCC phenotype 
and demonstrated that supplementation of PPi successfully stopped the progression of 
cardiac calcification but could not reverse already existing mineralization [33]. The 
success of these experiments led us to further investigate the acute calcification 
phenotype in skeletal muscles. We have chosen the gastrocnemius muscle as 
representative skeletal tissue because it is easily accessible to perform cryoinjury 
procedures and there is minimal impact on mobility post-surgery. We have also 
recovered and examined additional skeletal muscles that were injured as part of the 
DCC process, i.e. the incisions made to the abdominal muscles and cryoinjury of the 
diaphragm (see above description of DCC). 
These results ( 
Figure 7) show increased calcification after cryoinjury to the quadriceps muscle of 
Abcc6-/- mice and mirrored the DCC model in Abcc6-/- hearts. This skeletal muscle 
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dystrophic calcification phenotype was visualized histologically with H&E and Alizarin 
Red S staining of the injured quadriceps tissues. The injured WT gastrocnemius 
showed signs of tissue necrosis but there was no evidence of calcification after Alizarin 
Red staining. However, gastrocnemius tissues from the Abcc6-/- mouse showed injury 
and significant calcification at the area of injury. 
 
 
Figure 7: The cryoinjured Abcc6-/- quadriceps (skeletal muscle) with more calcification than WT.  
The H&E straining shows necrosis at the site of injury in both strains (A,B). The WT quadriceps did not 
exhibit calcification after injury (C), while the Abcc6-/- quadriceps exhibited significant calcification after 
injury (D). The significant increase in Abcc6-/- calcification is confirmed by the calcium assay (E). Scale 
(200 µM).  
Other tissues injured during survival procedures were also harvested for  
calcification analysis. The diaphragm, suture puncture wounds, and tissue folds of the 
incision sites in the abdominal area also displayed calcification (Figure 8).  
WT Quadriceps
A
liz
ar
in
 R
ed
Abcc6-/- Quadriceps
H
&
E
A B
C D
E
WT
 C
on
tro
l
WT
 In
jur
ed
Ab
cc
6-
/- C
on
tro
l
Ab
cc
6-
/- In
jur
ed
0.0
0.1
0.2
0.3
0.4
C
a2
+  (
m
g/
m
L/
g 
tis
su
e)
2014
Preliminary Data
Thigh Calcification
*
+/+
+ - +Injury
-/-+/+ -/-
-
*
C
al
ci
fic
at
io
n 
 (m
g/
m
L/
g 
tis
su
e)
 
Abcc6
ns
ns
 36 
 
Figure 8: Calcium staining of Abcc6-/- tissues injured in survival surgeries.  
The diaphragm (A) is injured during the transdiaphragm heart cryoinjury procedure and calcification is 
also observed at the puncture injury (B) and tissue folds (C) when suturing incisions closed. 
 
 
Approach and Significance: 
The acute DCC phenotype is now well characterized in the cardiac tissue of 
Abcc6-/- mice, but it is not known if this Abcc6-dependent calcification response is 
cardiac specific or affects other types of muscle tissues. To address this hypothesis, a 
preliminary study was initiated in 2014 in Dr. Le Saux’s laboratory related to skeletal 
muscle. Mouse quadriceps muscle was subjected to cryoinjury for 10 seconds and 
tissue samples were harvested seven days later for a calcium quantification assay and 
histology methods for calcium visualization to characterize the phenotype. 
The muscle cryoinjury and histological experiments were repeated in 2016 when 
I joined Dr. Le Saux’s laboratory to confirm these initial results. However, after several 
attempts at reproducing the results, there was no significant difference in calcium levels 
between the WT control and injured Abcc6-/- quadriceps (Figure 10E). It was unclear at 
the time if the lack of positive results were due to a current technical problem or if the 
2014 data were false positives. Therefore, we decided to optimize the skeletal muscle 
cryoinjury protocol to address this discrepancy. 
A B C
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Attempt to Optimize Cryoinjury Method to Induce Calcification 
The goal of adjusting the protocol was to ensure consistency between past and 
current cryoinjuries as well as tissue collection for calcification assays. First, a suture 
knot was sewn directly into the muscle to mark the area of injury. The cryoprobe was 
placed directly on top of the suture to cause injury. This step was important for tissue 
harvest after the injury has healed as it was much more difficult to visually delineate the 
injured region from the uninjured one than with cardiac tissues. Moreover, the time of 
injury was increased from 10 to 30 seconds to cause injury deeper into the muscle and 
improve the chances of detecting dystrophic calcification. Also, the injury site was 
changed from the quadriceps to the gastrocnemius because the gastrocnemius muscle 
had a larger surface area and was easier to access for survival surgeries and tissue 
harvest. Finally, only 50 µL instead of 200 µL of 0.15 N HCl were added to each sample 
during the calcium assay to increase the chance of detecting smaller calcium 
concentration in the supernatant after the 48-hour incubation period.  
After repeating our experiments with the adjusted protocol, there was significantly 
more calcium detected overall, yet the injured gastrocnemius of Abcc6-/- mice still did 
not have higher calcification as compared to the WT (Figure 10F) and no calcification 
could be visualized histologically in the Abcc6-/- gastrocnemius (Figure 10D). Taken 
altogether, the optimized protocol was only marginally successful in reproducing muscle 
calcification seen previously. 
Histological analyses of additional tissues were carried out when investigating 
the effectiveness of the optimized protocol. Before discovering the presence of high 
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concentration of PPi in animal chow, the diaphragm exhibited calcification even when 
on the high PPi diet.  
 
 
 
 
 
Figure 9: Calcification in the Abcc6-/- diaphragm 
with high PPi diet . 
The Abcc6-/- diaphragm exhibited calcification even 
when on the high PPi (2920) diet. 
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Figure 10: Attempted optimization of cryoinjury protocol only marginally successful with 
increased calcium quantified in injured Abcc6-/- gastrocnemius but not visualized histologically.  
Attempts at reproducing the preliminary skeletal muscle calcification data were unsuccessful (E) and 
necessitated protocol optimization. However, an increase in Abcc6-/- gastrocnemius calcification could not 
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be visualized histologically despite attempted protocol optimization (D). The altered protocol was 
marginally successful with an increase in calcium detected, but not to the significant levels initially 
detected in 2014 (F). 
 
Exogenous Sources of PPi  
Our inability to reproduce the preliminary calcification results of 2014 despite 
multiple attempts necessitated further investigation. The inconsistency of my results and 
the inability of Dr. Viola Pomozi - who is an expert in DCC [28, 33] - to induce DCC as 
part of another project raised the possibility that my results were not necessarily due to 
technical challenges.  
Our laboratory collectively hypothesized that the inhibited calcium development 
of the well-described acute calcification phenotype in cardiac and skeletal muscle 
tissues may be related to exogenous factors. The hypothesis of genetic changes or drift 
in Abcc6-/- mice was quickly ruled out since all mice are systematically genotyped. 
Based on prior published experiments, we have demonstrated that PPi 
supplementation, even in small or intermittent injection or oral delivery through water, 
was very effective at suppressing DCC [33, 34]. As PPi contamination either in the 
water supply or animal was a likely possibility, we developed a protocol to measure the 
presence of PPi in food, which has never been done before (see Method section).  
The PPi levels of the standard rodent diet and water at JABSOM were measured 
(Figure 11). The PPi content of the water was negligible. Conversely, we found a 
relatively high PPi content in the current standard chow, designated 2920. Indeed, if one 
assumes a daily consumption of ~4 g of food for an average mouse of about 25g, and a 
bioavailability of 0.5% (estimated from intraperitoneal injections), then the average daily 
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intake of PPi from the current diet would surpass the minimal PPi effective dose (Fig. x 
red line) previously estimated at ~3.5mg/kg/day [33]. Remarkably, the UH Animal 
Veterinary Services (AVS) had changed their supplier of animal chow during the second 
half of 2015. Thus, we further hypothesized that the chow formulation used in 2014 to 
generate our preliminary results probably contained a lower PPi content. We obtained a 
sample of animal chow used before 2015 (designated 5053) and measured its PPi 
content. Even though the food formulations of the pre- and post-2015 diets (5053 vs 
2920) were comparable (see supplementary data), our results showed that the 5053 
diet contained significantly less PPi compared to the post-2015 diet. Importantly, as our 
method to extract PPi from animal chow is performed in water at 4˚C, it is reasonable to 
assume that the process is relatively inefficient and the measures of the water 
supernatant are probably an underestimation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
20
16
 (H
I)
20
16
(B
p)
Pr
ior
 to
 20
15
 (H
I)
Pr
ior
 to
 20
15
 (B
p)
Bp
 C
ho
w
Dr
ink
ing
 W
ate
r
0
500
1000
1500
PP
i c
on
su
m
ed
 b
y 
m
ic
e 
(n
m
ol
/d
ay
)
PPi Measur me s in Chow
PPi Measurements of Chow
PP
i c
on
su
m
ed
 b
y 
m
ic
e 
 (n
m
ol
/d
ay
) 
n 
= 
3
n 
= 
3
n 
= 
3 
n 
= 
3 
n 
= 
3 
2016 2017
Lab Location
2016
HI BP
Before 
2015
Before 
2015
HI BP BP
Year
HI
n 
= 
4 
2017
Drinking 
Water
High PPi 
2920
High PPi 
2920
Diet
n 
= 
4 
Low PPi 
5053
Low PPi 
5053
N/A N/A
***
 42 
Figure 11: The 2016 rodent diet with a significantly higher concentration of PPi compared to diet 
used prior to 2015, and nominal PPi content in drinking water.  
The chow used in Hawaiʻi (HI) in 2016 (2920 diet) had significantly higher PPi content than the chow used 
before 2015 (5053 diet). These results were confirmed by the laboratory’s collaborators in Budapest (BP). 
The standard rodent chow in BP also had significantly lower PPi content than the 2920 diet. The PPi 
content of the drinking water was negligible. 
 
Moreover, to confirm these results, batches of both the 5053 and 2920 chow 
were sent to a collaborating investigator (Dr. Varadi) at the Hungarian Academy of 
Sciences, in Budapest. Dr. Varadi’s laboratory obtained similar PPi results (Figure 11). 
Furthermore, the Budapest group measured the PPi content of the standard rodent 
chow used at their institution, which was found to have a low PPi concentration like the 
pre-2015 5053 diet. To further test the hypothesis that the elevated PPi content of the 
current 2920 diet is indeed capable of inhibiting calcification development in our animal 
model, we compared calcification in vibrissae of mice on the current 2920 diet and 
results obtained prior to 2015. As discussed above, the calcification of vibrissae is an 
effective biomarker to quantify the chronic calcification phenotype in Abcc6-/- mice [19]. 
Vibrissae were harvested from 6 and 12 months old Abcc6-/- mice that were born and 
raised on the 2920 diet rich in PPi and the calcium content was assessed. Our results ( 
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Figure 12) showed that mice fed the high PPi diet (2920) had significantly less 
calcification in their vibrissae as compared to age-matched Abcc6-/- mice raised on the 
low PPi 5053 diet. These data provided strong evidence linking dietary PPi to lower 
calcification levels in Abcc6-/- mice.  
  
 
 
 
 
 
 
 
 
Figure 12: The High PPi diet is linked to reduced Abcc6-/- 
mice vibrissae calcification.  
The 6 month (6m) and 12 month (12m) old mice fed the high 
PPi diet (2920) had significantly less vibrissae calcification 
compared to the age-matched Abcc6-/- mice born and raised on 
the low PPi diet (5053). 
Ab
cc
6-
/-  o
ld 
die
t 6
m
Ab
cc
6-
/- ne
w 
die
t 6
m
Ab
cc
6-
/- ol
d d
iet
 12
m
Ab
cc
6-
/- ne
w 
die
t 1
2m
0.0
0.2
0.4
0.6
0.8
1.0
Whiskers calcification
C
a2
+  (
m
g/
m
L/
g 
tis
su
e)
****
****
Ab
cc
6-
/-  o
ld 
die
t 6
m
Ab
cc
6-
/- ne
w 
die
t 6
m
Ab
cc
6-
/- ol
d d
iet
 12
m
Ab
cc
6-
/- ne
w 
die
t 1
2m
0.0
0.2
0.4
0.6
0.8
1.0
Whiskers calcification
C
a2
+  (
m
g/
m
L/
g 
tis
su
e)
****
****
-/-Genotype -/- -/-
High PPiLow PPiDiet
-/-
Low PPi High PPi
Age 6m 6m12m 12m126m
 44 
 
 
Testing the effects of the PPi (2920) diet on Enpp1-/- mice.  
Our collaboration with Dr. Varadi’s laboratory in Hungary allowed us to test the 
efficacy of the high PPi diet (2920) on Enpp1-/- mice, which develop a calcification 
phenotype similar to Abcc6-/- animals at a faster rate beginning in utero [34]. 
Remarkably, the calcification phenotype of Enpp1-/- mice is strongly reduced when the 
animals are supplemented with PPi through water during the perinatal period [34]. The 
2920 diet was sent for testing on Enpp1-/- mice and preliminary results from Dr. Varadi’s 
laboratory indicate that the 2920 diet significantly reduced vibrissae calcification when 
provided during the perinatal period (Figure 11). 
 
Reverting to low PPi Diet 
Further experiments were done to investigate the effects of dietary PPi on the 
calcification phenotype. We tested whether substituting the current 2920 high PPi diet 
for the low PPi 5053 in adult Abcc6-/- mice would restore the acute dystrophic 
calcification phenotype. To test this hypothesis, we procured enough of the low PPi 
5053 diet directly from the manufacturer.  
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Both WT and Abcc6-/- mice were put on the low PPi diet for 1 week or up to 1 
month. At the end of these periods, mice were subjected to both cardiac and 
gastrocnemius cryoinjury. Tissues were harvested and excess calcium measured. 
Unexpectedly, reverting to the low PPi diet for 1 week had an effect opposite to our 
expectation, i.e. the calcification phenotype on both cardiac or gastrocnemius muscles 
was further reduced (Figure 13). Feeding the mice the low PPi diet for 1 month 
produced an effect similar to the calcification levels observed in heart tissues after a 1-
week period, whereas a non-significant trend upward was noted with the gastrocnemius 
muscle. 
 
 
Figure 13: Reverting to the low PPi (5053) diet caused a decrease in Abcc6-/- heart and 
gastrocnemius calcification. 
Reverting the Abcc6-/- mice to the low PPi (5053) diet for 1 week (1 wk) caused an unexpected further 
decrease in heart calcification (A) and gastrocnemius calcification (B). Neither tissue exhibited increased 
calcification despite keeping them on the low PPi diet for a longer period of 1 month (1 mo).   
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Acceleration Diet 
The acceleration diet (Acc) was created and published by another research 
group at the Department of Dermatology and Cutaneous Biology of Jefferson Medical 
College [27]. This diet contains specific mineral modifications to induce calcification in 
an Abcc6-/- mouse model. In comparison to the standard rodent diet, the Acc diet has a 
2-fold increase in absorbable phosphorus (from 0.43% to 0.85%), a 22-fold increase in 
vitamin D3 (from 4.4 IU/g to 100 IU/g), and a decrease in calcium (from 1.0% to 0.4%) 
and magnesium (from 0.22% to 0.04%) [40]. The Abcc6-/- mice on this experimental diet 
demonstrated faster and more pronounced vibrissae mineralization and extensive 
mineralization of other tissues such as kidneys, lungs, spleen, and the eyes [41]. Of 
note, lungs generally don’t present calcification in Abcc6-/- mice fed a normal diet [20] 
[19], whereas humans only show sub-clinical changes to pulmonary functions [42] and 
little mineralization [40] 
Although the phenotype induced by this Acc diet extends beyond the normal PXE 
mineralization, we have initiated testing of this diet to promote the development of 
dystrophic mineralization in our mouse model that (initially) failed to produce 
gastrocnemius calcification and failed to revert to a calcification-prone phenotype after 
switching to the 5053 diet.   
The same experimental setup was used with WT and Abcc6-/- mice that were fed the Acc diet for 1 
the Acc diet for 1 week or 1 month. The mice were subjected to both cardiac and skeletal muscle 
skeletal muscle cryoinjury followed by calcium quantification. Results ( 
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Figure 14) showed that levels of calcification increased in the heart and gastrocnemius but not 
enough to match the 2014 levels. Interestingly, the WT mice also showed evidence of 
mineralization despite the presence of a functional Abcc6 gene ( 
Figure 14). 
 
Figure 14: The Acc diet increased calcification in Abcc6-/- and WT mice.   
The Acc diet successfully induced calcification in heart (A) and gastrocnemius (B). However, even WT 
mice displayed calcification comparable to Abcc6-/- mice. 
 
Specific Aim 2:  
Explore gene expression and the role of the “Abcc6 pathway” and its molecular players 
(Abcc6, Enpp1, Nt5e, Tnap) in muscle calcification. 
 
Hypothesis:  
In the acute calcification phenotype, the lack of Abcc6 lowers ATP efflux and influences 
the expression of Enpp1, Nt5e, and Tnap, thereby impacting calcification susceptibility. 
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Approach and Significance  
Preliminary Data 
 Little is known about the gene expression changes that occur in Abcc6-/- 
muscular tissues after dystrophic calcification. Initial gene expression analyses in our 
laboratory showed that basal levels of Enpp1 and Nt5e expression were decreased in 
Abcc6-/- mice indicating that the absence of Abcc6 function influences gene expression 
downstream of Abcc6 [33]. Better understanding of the reaction of the molecular 
pathway downstream of Abcc6 could lead to better interventions to prevent dystrophic 
calcification in patients with PXE pathologies. 
 
 
 
 
Figure 15: Abcc6-/- livers with lower basal Enpp1 
expression.  
There is lower expression of Enpp1 in the liver of 
Abcc6-/- mice compared to WT. 
 
Optimizing Gene Expression Analysis 
We initially harvested tissues 7 days after cryoinjury to remain consistent with the 
DCC protocol and to ensure complete development of calcification. However, as the 
purpose of this aim was to measure changes in gene expression, it may not necessarily 
synchronize with calcification. 
To test this possibility, heart and gastrocnemius muscles were harvested at 1, 3, 
and 7-day time points post cryoinjury and Enpp1 expression was measured. We found 
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that the expression levels were significantly higher at 3 days post injury in both tissues, 
though for the heart a p-value could not be determined between day 1 and 3 because of 
the limited samples at day 1 (n=2) (Figure 16). Therefore, all gene expression 
determinations were performed subsequently 3 days after injury. 
 
 
 
 
Figure 16: The largest change in gene 
expression occurs 3 days after injury.  
The largest change in Enpp1 expression 
occurs 3 days after cryoinjury in both the 
heart and gastrocnemius. At 7 days, the 
gene expression appears to normalize.  
 
 
Gene Expression Results 
Both WT and Abcc6-/- gastrocnemius and heart exhibited a significant increase in 
Enpp1 and Nt5e expression specifically after injury (Figure 17). However, at baseline 
and after injury, there was no significant difference in Enpp1 or Nt5e expression 
between the WT and Abcc6-/- gastrocnemius samples (Figure 17A,C). Conversely, 
hearts from Abcc6-/- mice had significantly higher Enpp1 expression than the WT hearts 
3 days after injury (Figure 17C), while there was no statistically significant difference for 
Nt5e (Figure 17D). 
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The gene expression changes of Nt5e did not fully mirror that of Enpp1. In the 
gastrocnemius, the Nt5e expression increased significantly in WT animals after injury, 
however no significant increase was observed in Abcc6-/- mice due to the large 
variability between individual mice (Figure 17B). There was no significant difference in 
Nt5e expression post injury in WT mice, though we observed a significant rise after 
injury in Abcc6-/- samples (Figure 17D).  
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Figure 17: There is positive correlation with Abcc6 in expression of Enpp1 and Nt5e in the heart 
on the high PPi diet and a trend of increased Enpp1 expression 3 days after injury. 
A significant increase of both Enpp1 and Nt5e expression occurs after injury in both the gastrocnemius 
and heart. The Abcc6-/- hearts have a significantly higher expression of Enpp1 and Nt5e after injury in the 
heart. No differences in gene expression exist between the injured WT and Abcc6-/- gastrocnemius 
muscles. 
 
Changes in Gene Expression with the Acceleration Diet 
 WT and Abcc6-/- mice fed the Acc diet for 1 week were also analyzed for gene expression. 
expression. The diet had no significant effect on Enpp1 expression in the gastrocnemius and 
and heart tissues of WT and Abcc6-/- animals ( 
Figure 18). A p-value could not be determined between the control and injured Abcc6-/- 
gastrocnemius ( 
Figure 18A) and heart ( 
Figure 18B) due to limited sample size (n =  2) and (n =0) respectively. 
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Figure 18: Minimal conclusions could be drawn regarding the impact of the acceleration diet on 
Enpp1 expression in the heart and gastrocnemius. 
There is no significant change in Enpp1 expression between the control and injured WT gastrocnemius 
(A) and hearts (B). The limited sample size of the Abcc6-/- injured gastrocnemius and absence of data for 
Abcc6-/- injured gastrocnemius prevent us from drawing solid conclusions. 
 
Some Enpp1 expression experiments were carried out on the diaphragm since 
histological analysis showed calcification development despite being on the high PPi 
(2920) diet. However, no significant conclusions could be drawn due to limited sample 
sizes of WT injured and Abcc6-/- injured diaphragms (Figure 19). 
 
 
 
Figure 19: No conclusions could be drawn 
regarding the impact of the high PPi diet on 
diaphragm Enpp1 expression. 
The p-values could not be calculated due to 
limited sample sizes (red text). 
 
 
Specific Aim 3:  
Supplementation of PPi to counteract skeletal muscle calcification 
Hypothesis:  
The supplementation of PPi will reduce the amount of calcification in skeletal muscles.   
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Approach and Significance 
The original approach to investigating this aim was to supplement Abcc6-/- mice 
with PPi. Previous work published by our laboratory demonstrated that PPi 
supplementation through intraperitoneal (ip) injections prevented chronic and acute 
calcification in Abcc6-/- mice [28]. The difficulties we had in reproducing the acute 
calcification phenotype in skeletal muscle for Aim 1 (Figure 10) prevented us from 
conducting the necessary PPi supplementation experiments for this Aim.  
Some Enpp1 expression experiments were conducted to investigate if PPi 
supplementation impacted gene expression before discovering the presence of a high 
concentration of PPi in animal chow. These initial results showed that Enpp1 expression 
decreased significantly in the Abcc6-/- mice supplemented with PPi (Figure 20). 
Experiments for this aim were discontinued once we determined that the high PPi 
content of the standard animal diet could have skewed our data.  
 
 
 
Figure 20: PPi supplementation has a strong 
attenuate response in heart Enpp1 expression.  
The supplementation of PPi via ip injection to Abcc6-/- 
mice after cardiac cryoinjury significantly reduced 
Enpp1 expression in the heart.    
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PPi Through Diet 
Although we were unable to formally complete Aim 3, results obtained from the 
unexpectedly high PPi content of the animal chow from Aim 1 inadvertently provided 
information on how dietary PPi supplementation impacts the calcification phenotype. 
The high PPi content of the diet was discovered before conducting experiments for Aim 
3 and prevented us from conducting PPi supplementation experiments via ip injection. 
The investigation of dietary phosphate became the primary focus of my project due to 
the profound impact it had on my results.  
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CHAPTER 4: DISCUSSION AND FUTURE DIRECTIONS 
The unexpected consequences of dietary PPi on calcification  
The initial challenges encountered in reproducing the 2014 gastrocnemius 
calcification results ultimately altered the course of my original investigation. We 
identified the exogenous source of PPi as coming from the rodent diet. The results from 
this aim brought us to four main conclusions: 
1. Modest amounts of pyrophosphate found in the diet (Figure 11) has a 
profound effect on the chronic and acute calcification phenotypes. This was 
also confirmed with the preliminary results from our collaborators in Budapest 
with the Enpp1-/-/tip toe walking (ttw) mice (Error! Reference source not 
found.). 
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Figure 21: Dietary PPi appears to reduce calcification in Enpp1-/- mice(ttw) mice.  
Whisker calcification in Enpp1-/- mice. Mice were fed either low PPi diet (L-PPi) from Hungary or the 2920 
high PPi chow from Hawaiʻi (H-PPi). Because Enpp1-/- mice develop most calcification in utero, animals 
were exposed to control or high PPi chow during pregnancy through weaning. 
2. We have already successfully tested PPi supplementation through water and 
PPi in food may be another possible approach to alleviate or slow the 
progression of the PXE phenotype in patients through dietary changes. These 
results suggest dietary intervention may help mitigate pathologic calcification. 
One could consider consuming foods enriched with PPi or adding “PPi salt” to 
the diet. The addition of PPi to the diet is being tested in Budapest on healthy 
subjects and in Finland on PXE patients. PPi is a known additive in 
commercial food mixes that act as leavening, emulsifiers, and stabilizers 
important to maintaining quality shelf life of foods [5]. It is also added to 
flavored milk, cured meats, potato products, and canned fish [5]. High-
phosphorus foods include milk products and fast-food products like 
cheeseburgers. 
3. The varying amounts of PPi in food may explain the phenotypic heterogeneity 
in the PXE phenotype. Previous theories suggested that the lack of 
correlation between genotype and phenotype and intra-familial variations was 
due to modifier genes, but this was not proven despite multiple attempts [43-
46]. The different phenotypes and different severities in siblings with PXE 
may be explained by dietary preference. 
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4. Variations in standard chow between institutions and countries may explain 
divergent results and lack of reproducibility of results between laboratories. 
The importance of the Abcc6-/- mouse genetic background in PXE is now well 
understood, while that of the animal chow is not. Our study demonstrated the 
impact that diet may have on phenotypic outcome and highlights the 
differences between what is considered “standard chow” across institutions. 
It is important to consider the potential impact of genetic drift on the Abcc6-/- colony. 
Variants in the colony may result after 2 to 3 years and could provide a potential 
explanation as to why the Abcc6-/- mice are no longer calcifying after injury as expected. 
Although we do not have an idea of how the 2920 diet has become enriched in 
PPi, we explored the possibility that it may be linked to irradiation of the chow causing 
the breakdown of polyphosphates or polymerization of monophosphates. The 2020x 
diet is formulated identically to the 2920 (high PPi), except it is non-irradiated (non-irr). 
We procured a sample of the 2020x and no significant difference in PPi content was 
found. The source of PPi is still unknown.  
 
 
 
Figure 22: Radiation is not the source of 
increased PPi in the 2920 diet. 
There was no significant difference in PPi content 
between the irradiated (irr) and non-irradiated (non-
irr) foods. 
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The Acceleration diet may not be an appropriate tool for the Abcc6-/- mouse model 
The Acc diet was utilized as an attempt to compensate for the lack of positive results during the 
results during the initial part of the project, before we identified the presence of elevated levels of 
levels of PPi in the diet. The results showed that, in some cases, even WT mice displayed 
displayed calcification comparable to Abcc6-/- mice ( 
Figure 14), which suggests the high levels of Vitamin D3 present in this diet may 
induce acute calcification in muscle tissues in an Abcc6-independent manner. 
Moreover, the Acc diet may not be appropriate to use for dystrophic calcification studies 
and brings into question the previously published results on the chronic (passive) 
calcification phenotype [27, 40]. 
A unique response to injury in the diaphragm 
The diaphragm (a smooth muscle) and its response to injury was somewhat 
different than that of heart and skeletal muscle. The Abcc6-/- injured diaphragm exhibited 
calcification while being exposed to high levels of exogenous PPi in the diet (Figure 19). 
This suggests that exogenous PPi was less effective in this tissue and that the 
components of smooth muscle tissues may alter its response to injury. Gene expression 
showed a similar trend but a small sample size precluded us from establishing a formal 
conclusion. 
 
Reversion to the low PPi with unexpected results 
Changing back to the low PPi diet for short periods of time (1 week to 1 month) 
did not produce the expected return to higher levels of calcification in response to injury 
in the gastrocnemius muscle (Figure 13). This suggests that an adaptive mechanism 
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may be at play and that much more needs to be done to understand the role of PPi in 
ectopic calcification. 
 
Further molecular characterization of key players in the “ABCC6 pathway” 
Previous literature [25] [33] on Enpp1-/- mice suggests that the lack of Abcc6 
function alters the expression of the genes downstream (Enpp1, Nt5e, Alpl i.e. Tnap) in 
response to tissue injury and may be contributing to the DCC phenotype. The results 
obtained on Enpp1 expression in the heart (Figure 20) showed a strong attenuate 
response (probably product-dependent) to PPi supplementation. This notable change at 
the molecular level may be linked to the unexpected results of the Aim 1 skeletal muscle 
calcification phenotype results that were likely skewed due to high levels of dietary PPi.  
Enpp1 and Nt5e expression in the heart showed a positive correlation with Abcc6 
expression (Figure 17), where the injured Abcc6-/- group had significantly higher 
expression compared to injured WT. These encouraging results of Enpp1 and Nt5e 
expression in the heart support our hypothesis and experiments will be repeated with 
the mice being born and raised on the low PPi diet. Although basal levels of Enpp1 
expression were not significantly different in some groups (WT and Abcc6-/- 
gastrocnemius and heart), there is a trend that Enpp1 expression increases in response 
to injury. The absence of differences in gene expression between the WT and Abcc6-/- 
mice coincides with the Aim 1 data where the Abcc6-/- heart and gastrocnemius tissues 
did not calcify as we expected (Figure 13), which can be attributed to the increase in 
PPi in the circulation from the 2920 diet that inhibited calcification. Taken altogether, the 
absence of calcification and lack of significant changes in gene expression between the 
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WT and Abcc6-/- groups may be attributed to the inhibition of the calcification phenotype 
by PPi. 
As for Tnap (Alpl), the expression of this gene was low in the heart and skeletal 
muscles after using two probes, but this is not the first indication of this, as similar 
results found little expression in cardiac tissues [25]. This suggests that, contrary to 
what Ziegler et al suggested [26], TNAP in peripheral connective tissues plays a role in 
the chronic phenotype. This might not be the case for the acute dystrophic calcification 
phenotype affecting muscular tissues and, therefore, it is probable that Tnap does not 
play a role in the DCC phenotype. 
Conclusion 
 Overall, the elevated level of PPi in the diet produced valuable data that was just 
published. However, this prevented us from achieving the goals of the specific aims. 
Therefore, we intend to repeat many of these experiments with the 5053 diet. Given that 
reverting to the low PPi diet did not produce the expected rise in calcification post injury, 
these experiments will be conducted with animals being born and raised on the low PPi 
diet. The idea of PPi supplementation in humans is also being explored and is currently 
being tested on healthy subjects in Budapest. What was thought to be an innocuous 
change in diet formulation had a profound impact on the results and data reproducibility 
across our entire laboratory. Showing a possible link between dietary PPi and a 
decrease in calcification opens a new door to study how dietary intervention can be 
used to control and treat pathologic calcification.  
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